24We describe a method for measuring genome editing efficiency from in silico analysis of 25 high-resolution melt curve data. The melt curve data derived from amplicons of genome-26 edited or unmodified target sites were processed to remove the background fluorescent 27 signal emanating from free fluorophore and then corrected for temperature-dependent 28 quenching of fluorescence of double-stranded DNA-bound fluorophore. Corrected data 29 were normalized and numerically differentiated to obtain the first derivatives of the melt 30 curves. These were then mathematically modeled as a sum or superposition of minimal 31 number of Gaussian components. Using Gaussian parameters determined by modeling of 32 melt curve derivatives of unedited samples, we were able to model melt curve derivatives 33 from genetically altered target sites where the mutant population could be accommodated 34 using an additional Gaussian component. From this, the proportion contributed by the 35 mutant component in the target region amplicon could be accurately determined. Mutant 36 component computations compared well with the mutant frequency determination from 37 next generation sequencing data. The results were also consistent with our earlier studies 38 that used difference curve areas from high-resolution melt curves for determining the 39 efficiency of genome-editing reagents. The advantage of the described method is that it 40 does not require calibration curves to estimate proportion of mutants in amplicons of 41 genome-edited target sites. 42Homology-directed repair (HDR) either restores the original in the presence of an 49 endogenous template (sister chromatid) or inserts an exogenous DNA donor template 50 when available across the cut site [7][8][9]. 51The ability to generate genome-editing reagents with a desired specificity does not 52 guarantee efficient target site modification. There is therefore a need for methods that 53 rapidly assess reagent efficacy. A common approach is to determine efficacy of genome 54 editing reagents is to transfect human embryonic kidney (HEK293T) cell line with the 55 reagents. This is followed by amplification of target region by PCR and generation of 56 heteroduplexes by denaturation and renaturation in the presence of unmodified wild type 57 or different alleles. Mismatches in these heteroduplexes can be identified by digestion with 58 single-strand specific endonucleases (such as T7 or Surveyor nuclease) and resolution of 59 the digestion products in polyacrylamide or agarose gels [10][11][12]. 60A second approach to determine efficacy of genome editing is to use TaqMan assays with 61 probes designed to bind over the putative target cut site [12,13]. Reduced binding of the 62 TaqMan probe, due to indel mutations at the target site, with reference to a control 63TaqMan probe that binds outside the cut site, can be used to estimate the editing efficacy. 64 A third method, which is gaining popularity, uses high resolution melting analysis (HRMA) 65 after real-time PCR with nonspecific double-st...